University of California, San Francisco researchers have just begun an ambitious, decades-long study of gay, lesbian, bisexual, and transgender people, the first such study of its kind. And it all hinges on the iPhone. Scientists are hoping tens of thousands of people will download an app or participate in the study on a website, the San Francisco Chronicle reports.
The study, called Population Research in Identity and Disparities for Equality (yes, that's PRIDE for short), will look at a number of health concerns in the LGBT population, including HIV/AIDS, cancer, obesity, and depression. The app is part of Apple's ResearchKit tool, which has also unveiled apps to study conditions like breast cancer, cardiovascular disease, and diabetes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
The Week Unwrapped: Why are sinkholes becoming more common?Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
-
How Poland became Europe's military powerThe Explainer Warsaw has made its armed forces a priority as it looks to protect its borders and stay close to the US
-
Quiz of The Week: 15 - 21 FebruaryHave you been paying attention to The Week's news?
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
-
Bird flu one mutuation from human threat, study findsSpeed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
-
Dark chocolate tied to lower diabetes riskSpeed Read The findings were based on the diets of about 192,000 US adults over 34 years
